Dr. Michael Demetriou, MD

Dr. Demetriou practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Demetriou's NPI, 1992885099, was assigned on October 16, 2006. Dr. Demetriou graduated from University of Toronto Faculty of Medicine in 1996. Dr. Demetriou holds California license 000000A77231.

Dr. Demetriou's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Demetriou's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Demetriou to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demetriou practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Demetriou's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Demetriou is board certified in neurology by the Royal College of Physicians and Surgeons of Canada. Dr. Demetriou is licensed in California.

Dmand AI lists encephalopathy, multiple sclerosis and neuropathy among the conditions Dr. Demetriou treats.

CMS data shows 153 Medicare services from Dr. Demetriou across 3 procedure codes in 2024, for 49 Medicare patients. Medicare paid $9,197 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Demetriou in 2024. The largest group is 65 to 74, with 24 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Demetriou's median patient age at 60, with 69% women.

In 2024, Dr. Demetriou wrote 246 Medicare Part D claims for 36 patients. 57% of them were for generic drugs. CMS names the drug for 178 of them, across 6 drugs with 11 or more claims each, at $711,960 in total drug cost.

Dr. Demetriou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Demetriou as offering telehealth.

Dmand AI links 58 papers to Dr. Demetriou, published from 2007 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Polysaccharides, Glycosylation and N-Acetylglucosaminyltransferases. Dr. Demetriou has published most often in J Biol Chem. Dr. Demetriou's most frequent co-authors are James Williard Dennis, MD, Michael Yu Sy, MD and Donald William Kufe, MD.

Dr. Demetriou graduated from University of Toronto Faculty of Medicine in 1996.

Dr. Demetriou is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.